奥西默替尼                        
                
                                
                        
                            医学                        
                
                                
                        
                            内科学                        
                
                                
                        
                            肿瘤科                        
                
                                
                        
                            酪氨酸激酶                        
                
                                
                        
                            酪氨酸激酶抑制剂                        
                
                                
                        
                            化疗                        
                
                                
                        
                            癌症研究                        
                
                                
                        
                            表皮生长因子受体                        
                
                                
                        
                            癌症                        
                
                                
                        
                            埃罗替尼                        
                
                                
                        
                            受体                        
                
                        
                    
            作者
            
                David Planchard,Pasi A. Jänne,Ying Cheng,James Chih‐Hsin Yang,Noriko Yanagitani,Sang‐We Kim,Shunichi Sugawara,Yan Yu,Yun Fan,Sarayut Lucien Geater,К. К. Лактионов,Chee Khoon Lee,Natalia Valdiviezo,Samreen Ahmed,Jean-Marc Maurel,Igor Andrašina,Jonathan W. Goldman,Dana Ghiorghiu,Yuri Rukazenkov,Alex Todd            
         
                    
        
    
            
            标识
            
                                    DOI:10.1056/nejmoa2306434
                                    
                                
                                 
         
        
                
            摘要
            
            Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) that is selective for EGFR-TKI-sensitizing and
         
            
 
                 
                
                    
                    科研通智能强力驱动
Strongly Powered by AbleSci AI